The response of hyperlipoproteinemias to atromid and ethyl chlorophenoxyisobutyrate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The response of hyperlipoproteinemias to atromid and ethyl chlorophenoxyisobutyrate

Published:1963-09 Issue:5-6 Volume:3 Page:445-453
ISSN:0368-1319
Container-title:Journal of Atherosclerosis Research
language:en
Short-container-title:Journal of Atherosclerosis Research

Author:

Strisower E.H.

Publisher

Elsevier BV

Subject

General Medicine

Reference8 articles.

1. REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONE

2. EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATE

3. Univ. Calif. Radiation Laboratory Report 10794;Lindgren,1963

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clofibrate in Type II Hyperlipoproteinemia;Acta Medica Scandinavica;2009-04-24

2. Clinical Trial with Ethyl-α-p-Chlorophenoxyisobutyrate (Atromid-S) with Special Reference to White Blood Cell Counts;Acta Medica Scandinavica;2009-04-24

3. Effects of fibrates on serum lipids and atherosclerosis;Pharmacology & Therapeutics;1988-01

4. The effects of clofibrate and 3-amino-1,2,4-triazole on liver catalase and lipid metabolism in mice;Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism;1982-08

5. Triglycerides in clinical medicine A review;The American Journal of Clinical Nutrition;1978-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP